Eden Research PLC 2024 AR2
The report highlights Eden Research plc's financial and operational performance for the fiscal year 2024, showcasing a 34% increase in total revenue to £4.3m, driven by a 38% growth in product sales of Mevalone and Cedroz. Key milestones include receiving regulatory authorization for Mevalone in California, Germany, and Czechia, as well as emergency use authorization for Ecovelex in Italy. The company was named ESG Company of the Year at the 2024 Small Cap Network Awards. Eden continues to advance its ESG strategy, focusing on sustainable agriculture, reducing food waste, and developing plastic-free encapsulation technologies like Sustaine.
Company: Eden Research PLC
Sector: Professional & technical services
Country: United Kingdom
Year: 2024
Type: AR2
Pages: 112
Back to company
Eden Research PLC
Annual Report
The report highlights Eden Research plc's financial and operational performance for the fiscal year 2024, showcasing a 34% increase in total revenue to £4.3m, driven by a 38% growth in product sales of Mevalone and Cedroz. Key milestones include receiving regulatory authorization for Mevalone in California, Germany, and Czechia, as well as emergency use authorization for Ecovelex in Italy. The company was named ESG Company of the Year at the 2024 Small Cap Network Awards. Eden continues to advance its ESG strategy, focusing on sustainable agriculture, reducing food waste, and developing plastic-free encapsulation technologies like Sustaine.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees